Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchiolitis | 16 | 2023 | 462 | 3.770 |
Why?
|
| Asthma | 24 | 2024 | 6139 | 2.990 |
Why?
|
| Respiratory Syncytial Virus Infections | 8 | 2023 | 348 | 1.690 |
Why?
|
| Hypersensitivity | 3 | 2024 | 1138 | 1.190 |
Why?
|
| Genome-Wide Association Study | 19 | 2023 | 12217 | 1.110 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2021 | 17445 | 0.810 |
Why?
|
| Respiratory Syncytial Virus, Human | 5 | 2023 | 142 | 0.780 |
Why?
|
| Quantitative Trait, Heritable | 2 | 2019 | 527 | 0.660 |
Why?
|
| MicroRNAs | 5 | 2023 | 3748 | 0.650 |
Why?
|
| Metabolome | 4 | 2021 | 949 | 0.640 |
Why?
|
| Obesity, Abdominal | 1 | 2020 | 367 | 0.580 |
Why?
|
| Bronchiolitis, Viral | 3 | 2023 | 80 | 0.570 |
Why?
|
| Polymorphism, Single Nucleotide | 8 | 2022 | 15386 | 0.510 |
Why?
|
| Viruses | 3 | 2023 | 376 | 0.490 |
Why?
|
| Genetic Pleiotropy | 2 | 2019 | 174 | 0.460 |
Why?
|
| Multifactorial Inheritance | 1 | 2020 | 1297 | 0.410 |
Why?
|
| Infant | 17 | 2023 | 35456 | 0.360 |
Why?
|
| Obesity | 4 | 2022 | 12728 | 0.350 |
Why?
|
| Quantitative Trait Loci | 4 | 2023 | 2028 | 0.340 |
Why?
|
| Nasopharynx | 5 | 2022 | 389 | 0.320 |
Why?
|
| Anxiety Disorders | 1 | 2019 | 2683 | 0.310 |
Why?
|
| Polycystic Ovary Syndrome | 2 | 2022 | 370 | 0.300 |
Why?
|
| Energy Metabolism | 1 | 2019 | 2849 | 0.300 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2020 | 3148 | 0.300 |
Why?
|
| Biological Specimen Banks | 4 | 2020 | 737 | 0.280 |
Why?
|
| Depressive Disorder | 1 | 2019 | 3744 | 0.280 |
Why?
|
| Prospective Studies | 17 | 2023 | 53253 | 0.270 |
Why?
|
| Body Mass Index | 6 | 2022 | 12657 | 0.240 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2019 | 3670 | 0.240 |
Why?
|
| Rhinovirus | 5 | 2023 | 195 | 0.230 |
Why?
|
| Genetic Variation | 1 | 2019 | 6454 | 0.230 |
Why?
|
| Humans | 52 | 2024 | 746630 | 0.220 |
Why?
|
| Respiratory System | 2 | 2024 | 554 | 0.220 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3057 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3169 | 0.200 |
Why?
|
| Mannose | 1 | 2021 | 119 | 0.180 |
Why?
|
| Glomerulonephritis, IGA | 1 | 2021 | 64 | 0.180 |
Why?
|
| Picornaviridae Infections | 1 | 2021 | 90 | 0.180 |
Why?
|
| Pandemics | 1 | 2020 | 8443 | 0.180 |
Why?
|
| Protoporphyria, Erythropoietic | 1 | 2020 | 46 | 0.180 |
Why?
|
| Streptococcus pneumoniae | 2 | 2022 | 719 | 0.170 |
Why?
|
| Phenotype | 5 | 2023 | 16261 | 0.170 |
Why?
|
| Child | 11 | 2024 | 78492 | 0.170 |
Why?
|
| DNA Methylation | 3 | 2023 | 4259 | 0.160 |
Why?
|
| Genetic Loci | 2 | 2018 | 2556 | 0.160 |
Why?
|
| Arsenic Poisoning | 1 | 2018 | 54 | 0.160 |
Why?
|
| Interferon-alpha | 1 | 2022 | 902 | 0.150 |
Why?
|
| Alzheimer Disease | 1 | 2019 | 8305 | 0.150 |
Why?
|
| Fatty Acids | 2 | 2023 | 1777 | 0.150 |
Why?
|
| Elafin | 1 | 2017 | 31 | 0.150 |
Why?
|
| China | 2 | 2021 | 2294 | 0.150 |
Why?
|
| Linkage Disequilibrium | 2 | 2019 | 1963 | 0.150 |
Why?
|
| Leukocyte Elastase | 1 | 2017 | 112 | 0.140 |
Why?
|
| Waist Circumference | 1 | 2020 | 905 | 0.140 |
Why?
|
| Cardiovascular Diseases | 2 | 2019 | 15319 | 0.140 |
Why?
|
| Forced Expiratory Volume | 1 | 2021 | 1789 | 0.140 |
Why?
|
| Immunity | 1 | 2022 | 993 | 0.140 |
Why?
|
| Motor Skills | 1 | 2019 | 521 | 0.140 |
Why?
|
| Pneumonia, Ventilator-Associated | 1 | 2019 | 275 | 0.130 |
Why?
|
| Mendelian Randomization Analysis | 4 | 2021 | 942 | 0.120 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 740 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 1481 | 0.120 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2019 | 782 | 0.120 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 714 | 0.120 |
Why?
|
| Fetal Growth Retardation | 1 | 2018 | 572 | 0.120 |
Why?
|
| Risk Factors | 8 | 2022 | 72447 | 0.120 |
Why?
|
| Severity of Illness Index | 3 | 2020 | 15555 | 0.110 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2023 | 2869 | 0.110 |
Why?
|
| Inflammation Mediators | 1 | 2022 | 1858 | 0.110 |
Why?
|
| Meta-Analysis as Topic | 1 | 2018 | 1357 | 0.110 |
Why?
|
| Fasting | 1 | 2019 | 1577 | 0.110 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2022 | 11966 | 0.100 |
Why?
|
| Epigenomics | 1 | 2018 | 911 | 0.100 |
Why?
|
| Immunoglobulin E | 3 | 2023 | 1496 | 0.100 |
Why?
|
| Databases, Genetic | 1 | 2019 | 1732 | 0.100 |
Why?
|
| Female | 19 | 2022 | 382450 | 0.100 |
Why?
|
| Glycoproteins | 1 | 2019 | 2221 | 0.100 |
Why?
|
| Fibrinolysis | 1 | 2013 | 323 | 0.100 |
Why?
|
| Survival Analysis | 4 | 2018 | 10138 | 0.100 |
Why?
|
| Respiration, Artificial | 2 | 2019 | 2573 | 0.100 |
Why?
|
| Endotoxemia | 1 | 2013 | 201 | 0.100 |
Why?
|
| Male | 17 | 2021 | 351420 | 0.100 |
Why?
|
| Blood Glucose | 3 | 2022 | 6222 | 0.090 |
Why?
|
| Logistic Models | 3 | 2021 | 13170 | 0.090 |
Why?
|
| Developmental Disabilities | 1 | 2019 | 1494 | 0.090 |
Why?
|
| Birth Weight | 1 | 2018 | 2060 | 0.090 |
Why?
|
| Particulate Matter | 1 | 2021 | 2518 | 0.090 |
Why?
|
| Mental Disorders | 1 | 2019 | 6639 | 0.090 |
Why?
|
| Adult | 10 | 2022 | 215192 | 0.080 |
Why?
|
| Hospitalization | 4 | 2023 | 10333 | 0.080 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 2679 | 0.080 |
Why?
|
| Overweight | 1 | 2020 | 2389 | 0.080 |
Why?
|
| Acute Lung Injury | 1 | 2013 | 370 | 0.080 |
Why?
|
| Comorbidity | 2 | 2020 | 10372 | 0.080 |
Why?
|
| Models, Genetic | 1 | 2019 | 3425 | 0.080 |
Why?
|
| Internationality | 1 | 2014 | 981 | 0.080 |
Why?
|
| Air Pollution | 1 | 2022 | 2288 | 0.080 |
Why?
|
| Cytokines | 1 | 2023 | 7236 | 0.080 |
Why?
|
| Heart Rate | 1 | 2019 | 4041 | 0.080 |
Why?
|
| Insulin | 2 | 2022 | 6479 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2023 | 12767 | 0.080 |
Why?
|
| Air Pollutants | 1 | 2022 | 2806 | 0.080 |
Why?
|
| Child Development | 1 | 2019 | 2251 | 0.080 |
Why?
|
| Environmental Exposure | 1 | 2022 | 4315 | 0.070 |
Why?
|
| Developing Countries | 1 | 2019 | 2803 | 0.070 |
Why?
|
| Case-Control Studies | 3 | 2021 | 21693 | 0.070 |
Why?
|
| Blood Coagulation | 1 | 2013 | 1138 | 0.070 |
Why?
|
| Middle Aged | 9 | 2021 | 214618 | 0.070 |
Why?
|
| Thrombocytopenia | 1 | 2014 | 1159 | 0.070 |
Why?
|
| Infant, Newborn | 2 | 2024 | 25759 | 0.070 |
Why?
|
| Heparin | 1 | 2013 | 1630 | 0.060 |
Why?
|
| Child, Preschool | 3 | 2022 | 41390 | 0.060 |
Why?
|
| Lung | 2 | 2021 | 9918 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2018 | 5031 | 0.050 |
Why?
|
| Neurogenesis | 1 | 2019 | 840 | 0.050 |
Why?
|
| Random Allocation | 2 | 2018 | 2388 | 0.050 |
Why?
|
| Aged | 7 | 2021 | 164383 | 0.050 |
Why?
|
| Hospital Mortality | 1 | 2016 | 5217 | 0.050 |
Why?
|
| Sphingomyelins | 1 | 2022 | 103 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2020 | 40534 | 0.050 |
Why?
|
| Cognition | 1 | 2019 | 6782 | 0.050 |
Why?
|
| Haemophilus influenzae | 1 | 2022 | 173 | 0.050 |
Why?
|
| Proteome | 2 | 2022 | 1813 | 0.050 |
Why?
|
| Intensive Care Units | 3 | 2021 | 3674 | 0.050 |
Why?
|
| Ceramides | 1 | 2022 | 202 | 0.050 |
Why?
|
| Ferrochelatase | 1 | 2020 | 47 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 6457 | 0.040 |
Why?
|
| APACHE | 1 | 2021 | 268 | 0.040 |
Why?
|
| Hypertension | 1 | 2020 | 8366 | 0.040 |
Why?
|
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2019 | 49 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 5295 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2020 | 205 | 0.040 |
Why?
|
| Adolescent | 3 | 2024 | 86278 | 0.040 |
Why?
|
| Platelet Function Tests | 1 | 2020 | 285 | 0.040 |
Why?
|
| Respiratory Sounds | 1 | 2023 | 688 | 0.040 |
Why?
|
| Proportional Hazards Models | 3 | 2021 | 12280 | 0.040 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2019 | 169 | 0.040 |
Why?
|
| Language Development | 1 | 2019 | 181 | 0.040 |
Why?
|
| Proteomics | 2 | 2022 | 3709 | 0.040 |
Why?
|
| Platelet Count | 1 | 2020 | 762 | 0.040 |
Why?
|
| Time Factors | 2 | 2016 | 39622 | 0.040 |
Why?
|
| Epigenesis, Genetic | 2 | 2021 | 3654 | 0.040 |
Why?
|
| Prostatic Neoplasms | 1 | 2020 | 11215 | 0.040 |
Why?
|
| Adiponectin | 1 | 2022 | 1100 | 0.030 |
Why?
|
| Mice | 2 | 2021 | 80251 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2020 | 9599 | 0.030 |
Why?
|
| Docosahexaenoic Acids | 1 | 2022 | 892 | 0.030 |
Why?
|
| Arsenic | 1 | 2018 | 337 | 0.030 |
Why?
|
| Lipoproteins, HDL | 1 | 2019 | 656 | 0.030 |
Why?
|
| Positive-Pressure Respiration | 1 | 2019 | 628 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2022 | 2273 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2019 | 837 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2019 | 1137 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2018 | 13218 | 0.030 |
Why?
|
| Europe | 1 | 2020 | 3355 | 0.030 |
Why?
|
| Telomere | 1 | 2019 | 905 | 0.030 |
Why?
|
| Patient Admission | 1 | 2021 | 1358 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 1758 | 0.030 |
Why?
|
| Inflammation | 1 | 2013 | 10633 | 0.030 |
Why?
|
| Animals | 3 | 2021 | 166558 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 6102 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2022 | 3161 | 0.030 |
Why?
|
| Lipids | 1 | 2023 | 3290 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2020 | 20763 | 0.030 |
Why?
|
| Cardiovascular System | 1 | 2019 | 830 | 0.030 |
Why?
|
| Fetal Blood | 1 | 2018 | 1318 | 0.020 |
Why?
|
| Triglycerides | 1 | 2019 | 2433 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 2398 | 0.020 |
Why?
|
| Metabolomics | 1 | 2019 | 1571 | 0.020 |
Why?
|
| Prognosis | 2 | 2021 | 29079 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2013 | 1140 | 0.020 |
Why?
|
| Mortality | 1 | 2020 | 2854 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2021 | 23464 | 0.020 |
Why?
|
| Placenta | 1 | 2018 | 1682 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2013 | 1857 | 0.020 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2019 | 2885 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2019 | 8294 | 0.020 |
Why?
|
| Gene Expression | 1 | 2021 | 7590 | 0.020 |
Why?
|
| Critical Illness | 1 | 2021 | 2693 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2019 | 4414 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 57586 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2017 | 6789 | 0.020 |
Why?
|
| Length of Stay | 1 | 2019 | 6293 | 0.020 |
Why?
|
| Genomics | 1 | 2022 | 5695 | 0.020 |
Why?
|
| Genotype | 1 | 2019 | 12788 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2018 | 11078 | 0.010 |
Why?
|
| Survival Rate | 1 | 2017 | 12645 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 10096 | 0.010 |
Why?
|
| Prevalence | 1 | 2019 | 15312 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 17869 | 0.010 |
Why?
|
| Boston | 1 | 2014 | 9213 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 12021 | 0.010 |
Why?
|
| Young Adult | 2 | 2018 | 57163 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2021 | 23154 | 0.010 |
Why?
|
| Algorithms | 1 | 2019 | 13810 | 0.010 |
Why?
|
| Pregnancy | 1 | 2018 | 29297 | 0.010 |
Why?
|
| Rats | 1 | 2013 | 23696 | 0.010 |
Why?
|
| Mutation | 1 | 2020 | 29627 | 0.010 |
Why?
|
| United States | 1 | 2021 | 70437 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2019 | 63732 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2018 | 78313 | 0.010 |
Why?
|
Concepts
(201)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(37)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_